Showing results (241-250 of 383) with videos related to
Sort By:
Pageof 39
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2011
Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney diseaseAmy C Wilson, Michael F Schneider, Christopher Cox, et al.Kidney International|June 10, 2011
Universal GFR determination based on two time points during plasma iohexol disappearanceDerek K S Ng, George J Schwartz, Lisa P Jacobson, et al.Annals of Pediatrics|October 17, 2025
COVID-19 Associated Worry and Emotional Distress in Youth and Young Adults with Chronic Kidney DiseaseJoann Carlson, Erin M Jones, Sharon Manne, et al.The Journal of Urology|August 23, 2011
Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rateJennifer L Dodson, Judith V Jerry-Fluker, Derek K Ng, et al.Pediatric Nephrology (Berlin, Germany)|August 25, 2018
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysisWinnie Y Sohn, Anthony A Portale, Isidro B Salusky, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 14, 2017
FGF23 and Left Ventricular Hypertrophy in Children with CKDMark M Mitsnefes, Aisha Betoko, Michael F Schneider, et al.Pediatric Nephrology (Berlin, Germany)|July 25, 2014
Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborativeAlicia M Neu, Marlene R Miller, Jayne Stuart, et al.Journal of Clinical Epidemiology|October 23, 2024
GRADE Notes 4: how to use GRADE when there is "no" evidence? A case study of using unpublished registry dataIbrahim K El Mikati, Brandy Begin, Dagmara Borzych-Duzalka, et al.Pediatric Nephrology (Berlin, Germany)|December 12, 2018
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysisWinnie Y Sohn, Anthony A Portale, Isidro B Salusky, et al.Pediatric Nephrology (Berlin, Germany)|September 14, 2017
Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney diseaseSahar Fathallah-Shaykh, Dorota Drozdz, Joseph Flynn, et al.Pageof 39